External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Roche and Genentech at

CHEST 2022

-
Coming soon
01:30 PM
Duration 4mins Convention Center Exhibit Hall: Rapid Area 4B
Post-hoc analysis of clinical characteristics and outcomes in patients with idiopathic pulmonary fibrosis (IPF) by pulmonary vascular phenotype from CAPACITY
Saggar R, Nathan S, Chakinala M, Joshua J, Gupta S, Trzaskoma B, Lancaster L

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
Duration 4mins Convention Center Exhibit Hall: Rapid Area 1C
Efficacy of Pirfenidone on Dyspnea in Patients with Idiopathic Pulmonary Fibrosis (IPF): Results from a Post-Hoc Responder Analysis
Glassberg MK, Thavarajah K, Collins BF, Gupta S, Trzaskoma B, Kirchgaessler KU, Devine J, Raghu G

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar